You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

Litigation Details for ERFINDERGEMEINSCHAFT UROPEP GbR v. Eli Lilly and Company (E.D. Tex. 2015)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in ERFINDERGEMEINSCHAFT UROPEP GbR v. Eli Lilly and Company
The small molecule drugs covered by the patents cited in this case are ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , and ⤷  Sign Up .
Biologic Drugs cited in ERFINDERGEMEINSCHAFT UROPEP GbR v. Eli Lilly and Company
The biologic drugs covered by the patents cited in this case are ⤷  Sign Up and ⤷  Sign Up .

Details for ERFINDERGEMEINSCHAFT UROPEP GbR v. Eli Lilly and Company (E.D. Tex. 2015)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2016-08-08 129 Response in Opposition to Motion 9,393,238 issued July 19, 2016 and is assigned to Celgene. Ex. 53, App. at 1065. It claims a method… ’124 patent contributed to your conclusion that the claims of the ’124 patent lack written…potentially, thousands of patents and dozens of Lilly’s. 10 We will return to the patent at issue in Avanir…To Existing Patents, Including Lilly’s There are 27,465 United States patents with claims …numerous patents that could be dramatically impacted by Lilly’s argument. For example, U.S. Patent No. 9,393,238 External link to document
2016-08-08 130 Exhibit 65 - U.S. Patent RE38,115 E 463756A1, # 4 Exhibit 53 - U.S. Patent 9,393,238, # 5 Exhibit 54 - Lilly Patents with Claim Term Inhibitor,…Inhibitor, # 6 Exhibit 55 - U. S. Patent 5,674,887, # 7 Exhibit 56 - U.S. Patent 6,451,807, # 8 Exhibit 57 - Sybertz…2009), # 19 Exhibit 68 - U.S. Patent 6,245,802, # 20 Exhibit 69 - U.S. Patent 6,492,371, # 21 Exhibit 70 … Sybertz (1995), # 9 Exhibit 58 - U.S. Patent 5,393,755, # 10 Exhibit 59 - EP 0579496 A1, # 11 Exhibit…Claim Construction Hearing, # 16 Exhibit 65 - U.S. Patent RE38,115 E, # 17 Exhibit 66 - Mayo Clinic List External link to document
2017-02-07 198 Motion in Limine 0001-5 2. Pfizer U.S. Patent No. 6,469,012 …Parte Reexamination Certificate for U.S. Patent No. 6,469,012 0053-87 4. Ex Parte…the ‘124 Patent”) nor prior art to the ‘124 Patent in an attempt to bolster the ‘124 Patent’s disclosure…compare the ‘124 Patent to Lilly’s U.S. Patent No. 6,451,807 (“the ‘807 Patent”) in both its present…Meaning, or Scope of the ‘124 Patent Drawn from Unrelated Patents. ........................ External link to document
2015-11-03 38 Response in Opposition to Motion at 1 (D.N.J. Oct. 11, 2007) (citing U.S. Patent No. 6,455,557). The district court in that case construed…Lilly and Brookshire infringe U.S. Patent No. 8,791,124 (“the ʼ124 Patent”) through the sale of Cialis® for…Direct Infringement of the ’124 Patent. Claim 1 of the ’124 Patent recites, in pertinent part, “… Brookshire for Direct Infringement of the ’124 Patent. .........................................7  …Brookshire for Indirect Infringement of the ’124 Patent. ....................................11  IV.  External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.